Fosfomycin: an old, new friend? (Q37633415)

21 August 2017

1 reference

title

Fosfomycin: an old, new friend? (English)

1 reference

21 August 2017

M Popovic

1

1 reference

21 August 2017

D Steinort

series ordinal

2

1 reference

21 August 2017

S Pillai

series ordinal

3

1 reference

21 August 2017

C Joukhadar

series ordinal

4

1 reference

21 August 2017

14 November 2009

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

21 August 2017

1 reference

21 August 2017

29

1 reference

21 August 2017

2

1 reference

21 August 2017

127-142

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-009-0833-2

21 August 2017

0 references

cites work

In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

In vitro activities of new antimicrobial agents against multiresistant Staphylococcus aureus isolated from septicemic patients during a Belgian national survey from 1983 to 1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Cloning and sequencing of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Plasmid-determined resistance to fosfomycin in Serratia marcescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Plasmid-mediated fosfomycin resistance is due to enzymatic modification of the antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Cloning and molecular epidemiology of plasmid-determined fosfomycin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Plasmid-encoded fosfomycin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Formation of an adduct between fosfomycin and glutathione: a new mechanism of antibiotic resistance in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Purification of a glutathione S-transferase that mediates fosfomycin resistance in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Product of fosC, a gene from Pseudomonas syringae, mediates fosfomycin resistance by using ATP as cosubstrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Single- and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Second-line treatment of limb-threatening diabetic foot infections with intravenous fosfomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

[Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in Spain: a comparative multicenter study (2002-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Beta-lactam-fosfomycin antagonism involving modification of penicillin-binding protein 3 in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-009-0833-2

Antibiotic abscess penetration: fosfomycin levels measured in pus and simulated concentration-time profiles

21 January 2018

1 reference

12 December 2020

In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis model

1 reference

12 December 2020

Pharmacokinetics of fosfomycin

1 reference

12 December 2020

[Differential diagnosis of unilateral hilar enlargement: Castleman tumor]

1 reference

12 December 2020

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

1 reference

12 December 2020

Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives

1 reference

12 December 2020

Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.

1 reference

12 December 2020

Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration

1 reference

12 December 2020

Nucleotide sequence of the fosB gene conferring fosfomycin resistance in Staphylococcus epidermidis

1 reference

12 December 2020

Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods

1 reference

12 December 2020

In vitro activity of fosfomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

1 reference

12 December 2020

Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus.

1 reference

12 December 2020

[Preliminary study of the antagonistic effects between fosfomycin and beta-lactams on Pseudomonas aeruginosa observed on the antibiogram]

1 reference

12 December 2020

[Improvement of the therapeutic efficacy of fosfomycin by addition of glucose-6-phosphate in the treatment of intraperitoneally infected mice (author's transl)]

1 reference

12 December 2020

Fosfomycin Treatment of <i>Haemophilus influenzae </i>Infection in Mice

1 reference

12 December 2020

[Clinical usefulness of the combined empirical therapy with flomoxef and fosfomycin for intractable respiratory tract infections. With a background of increasing MRSA incidence]

1 reference

12 December 2020

Choice of first-line antibiotic therapy in the treatment of bone and joint infections in children

1 reference

12 December 2020

Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues.

1 reference

12 December 2020

Antimicrobial activity of fosfomycin in vitro.

1 reference

12 December 2020

Clinical pharmacology and in vitro activity of phosphonomycin

1 reference

12 December 2020

Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

1 reference

12 December 2020

The trometamol salt of fosfomycin: microbiological evaluation.

1 reference

12 December 2020

Determination of fosfomycin in pus by capillary zone electrophoresis

1 reference

12 December 2020

Adjuvant fosfomycin medication in chronic osteomyelitis

1 reference

12 December 2020

Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa

1 reference

12 December 2020

Fosfomycin: Laboratory Studies

1 reference

12 December 2020

Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin.

1 reference

12 December 2020

[Concentrations of fosfomycin in serum and lung tissue]

1 reference

12 December 2020

Fosfomycin/metronidazole compared with doxycycline/metronidazole for the prophylaxis of infection after elective colorectal surgery. A randomised double-blind multicentre trial in 517 patients

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus endocarditis following patch closure of a ventricular septal defect: report of a case

1 reference

12 December 2020

In-vitro activity of imipenem combined with beta-lactam antibiotics for methicillin-resistant Staphylococcus aureus.

1 reference

12 December 2020

Experimental endocarditis and fosfomycin

1 reference

12 December 2020

Pharmacokinetics of disodium-fosfomycin in mongrel dogs

1 reference

12 December 2020

Target site bacterial killing of cefpirome and fosfomycin in critically ill patients

1 reference

12 December 2020

Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections.

1 reference

12 December 2020

Serum and lung tissue levels of fosfomycin in humans

1 reference

12 December 2020

Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.

1 reference

12 December 2020

[Comparison of fosfomycin-penicillin M and penicillin M-gentamycin. Apropos of 35 severe infections caused by methicillin-sensitive Staphylococcus aureus]

1 reference

12 December 2020

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli

1 reference

12 December 2020

Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?

1 reference

12 December 2020

Chromosomal localization of resistance to fosfomycin and aminocyclitol antibiotics in hospital strains of Staphylococcus aureus

1 reference

12 December 2020

Pharmacodynamics of phosphonomycin after oral administration in man

1 reference

12 December 2020

In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin

1 reference

12 December 2020

Isolation and characterization of mutations affecting the transport of hexose phosphates in Escherichia coli

1 reference

12 December 2020

International collaborative study on standardization of bacterial sensitivity to fosfomycin

1 reference

12 December 2020

Immunomodulatory effects of fosfomycin in an endotoxin model in human blood.

1 reference

12 December 2020

In-vitro activity of fosfomycin against vancomycin-resistant enterococci

1 reference

12 December 2020

Bactericidal activity of cefotaxime and fosfomycin in cerebrospinal fluid during the treatment of rabbit meningitis experimentally induced by methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Isolation and Characterization of a Phosphonomycin-Resistant Mutant of Escherichia coli K-12

1 reference

12 December 2020

Glycerol dissimilation and its regulation in bacteria

1 reference

12 December 2020

Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections.

1 reference

12 December 2020

In vivo activity and pharmacodynamics of amoxicillin in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae

1 reference

12 December 2020

In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.

1 reference

12 December 2020

Fosfomycin and Plasmidic Resistance

1 reference

12 December 2020

Pharmacokinetics of a single bolus intravenous, intramuscular and subcutaneous dose of disodium fosfomycin in horses

1 reference

12 December 2020

[Perioperative preventive antibiotic treatment with fosfomycin in heart surgery: serum kinetics in extracorporeal circulation and determination of concentration in heart valve tissue]

1 reference

12 December 2020

Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin.

1 reference

12 December 2020

Two kinds of mutants defective in multiple carbohydrate utilization isolated from in vitro fosfomycin-resistant strains of Escherichia coli K-12

1 reference

12 December 2020

Pharmacokinetics of Phosphonomycin in Man I:Intravenous Administration

1 reference

12 December 2020

Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis.

1 reference

12 December 2020

Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci

1 reference

12 December 2020

In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood

1 reference

12 December 2020

Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome

1 reference

12 December 2020

Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbits.

1 reference

12 December 2020

Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing Escherichia coli O26

1 reference

12 December 2020

Fosfomycin for the initial treatment of acute haematogenous osteomyelitis

1 reference

12 December 2020

Target site penetration of fosfomycin in critically ill patients

1 reference

12 December 2020

Fosfomycin in Osteomyelitis

1 reference

12 December 2020

Plasmid-mediated resistance to fosfomycin in Staphylococcus epidermidis.

1 reference

12 December 2020

Phosphonomycin: structure and synthesis

1 reference

12 December 2020

Fosfomycin resistance: selection method for internal and extended deletions of the phosphoenolpyruvate:sugar phosphotransferase genes of Salmonella typhimurium

1 reference

12 December 2020

Novel Fosfomycin resistance of Pseudomonas aeruginosa clinical isolates recovered in Japan in 1996.

1 reference

12 December 2020

The mechanism of action of fosfomycin (phosphonomycin)

1 reference

12 December 2020

Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges

1 reference

12 December 2020

Efficacy of phosphonomycin in treatment of urinary-tract infections

1 reference

12 December 2020

Fosfomycin trometamol versus amoxycillin--single-dose multicenter study of urinary tract infections

1 reference

12 December 2020

Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus

1 reference

12 December 2020

[Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].

1 reference

12 December 2020

High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection.

1 reference

12 December 2020

Enterocolitis with pathogenic Escherichia coli infection in renal transplant recipients: case reports

1 reference

12 December 2020

Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis.

1 reference

12 December 2020

Characterization of staphylococcal plasmids hybridizing with the fosfomycin resistance gene fosB

1 reference

12 December 2020

[Studies of the penetrating ability of fosfomycin into the aqueous humor and vitreous body of the eye]

1 reference

12 December 2020

Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs

1 reference

12 December 2020

Fosfomycin, a new antibiotic drug (author's transl)

1 reference

12 December 2020

[Clinical studies on fosfomycin sodium following intravenous administration (tissue concentration and clinical efficacy)].

1 reference

12 December 2020

Heterologous production of fosfomycin and identification of the minimal biosynthetic gene cluster

1 reference

12 December 2020

[Critical study on methods for determining antibiotic tissue levels in humans (author's transl)]

1 reference

12 December 2020

[The open plate, a decisive part of today's osteitis therapy]

1 reference

12 December 2020

Ocular penetration kinetics of fosfomycin administered as a one-hour infusion

1 reference

12 December 2020

In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus

1 reference

12 December 2020

Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections

1 reference

12 December 2020

1 reference

12 December 2020

Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey.

1 reference

12 December 2020

Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis

1 reference

12 December 2020

In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance

1 reference

12 December 2020

Fosfomycin levels in human aqueous humor after intravenous administration.

1 reference

12 December 2020

Pharmacokinetic profile of fosfomycin trometamol.

1 reference

12 December 2020

Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data

1 reference

12 December 2020

Fosfomycin in paediatric cancer patients: a feasible alternative to glycopeptides?

1 reference

12 December 2020

[Fosfomycin levels in the cerebrospinal fluid of patients with and without meningitis]

1 reference

12 December 2020

In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics.

1 reference

12 December 2020

In vitro activity of fosfomycin in combination with various antistaphylococcal substances.

1 reference

12 December 2020

Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces

1 reference

12 December 2020

[Antibiotic prophylaxis using a combination of pefloxacin and fosfomycin in heart surgery with CEC (extracorporeal circulation) in patients allergic to beta-lactams]

1 reference

12 December 2020

Introducing fosfomycin for surgical prophylaxis--emergence of resistance in aerobic faecal gram-negative bacteria of in-patients, but not among strains causing infection after elective colorectal procedures

1 reference

12 December 2020

The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system.

1 reference

12 December 2020

10.1007/S10096-009-0833-2

Identifiers

DOI

1 reference

21 August 2017

1 reference